BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Conte G, Menéndez-Méndez A, Bauer S, El-Naggar H, Alves M, Nicke A, Delanty N, Rosenow F, Henshall DC, Engel T. Circulating P2X7 Receptor Signaling Components as Diagnostic Biomarkers for Temporal Lobe Epilepsy. Cells 2021;10:2444. [PMID: 34572093 DOI: 10.3390/cells10092444] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Wong ZW, Engel T. More than a drug target: Purinergic signalling as a source for diagnostic tools in epilepsy. Neuropharmacology 2023;222:109303. [DOI: 10.1016/j.neuropharm.2022.109303] [Reference Citation Analysis]
2 Engel T, Jiménez-mateos EM, Diaz-hernandez M. Purinergic Signalling and Inflammation-Related Diseases. Cells 2022;11:3748. [DOI: 10.3390/cells11233748] [Reference Citation Analysis]
3 Guerra Leal B, Barros-barbosa A, Ferreirinha F, Chaves J, Rangel R, Santos A, Carvalho C, Martins-ferreira R, Samões R, Freitas J, Lopes J, Ramalheira J, Lobo MG, Martins da Silva A, Costa PP, Correia-de-sá P. Mesial Temporal Lobe Epilepsy (MTLE) Drug-Refractoriness Is Associated With P2X7 Receptors Overexpression in the Human Hippocampus and Temporal Neocortex and May Be Predicted by Low Circulating Levels of miR-22. Front Cell Neurosci 2022;16:910662. [DOI: 10.3389/fncel.2022.910662] [Reference Citation Analysis]
4 García-Villalba J, Hurtado-Navarro L, Peñín-Franch A, Molina-López C, Martínez-Alarcón L, Angosto-Bazarra D, Baroja-Mazo A, Pelegrin P. Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease Severity. Front Immunol 2022;13:894470. [PMID: 35663992 DOI: 10.3389/fimmu.2022.894470] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Mahmood A, Villinger A, Iqbal J. Therapeutic potentials and structure-activity relationship of 1,3-benzodioxole N-carbamothioyl carboxamide derivatives as selective and potent antagonists of P2X4 and P2X7 receptors. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114491] [Reference Citation Analysis]
6 García-villalba J, Hurtado-navarro L, Peñín-franch A, Molina-lópez C, Martínez-alarcón L, Angosto-bazarra D, Baroja-mazo A, Pelegrín P. Soluble P2X7 receptor is elevated in the plasma of COVID-19 patients and correlates with disease severity.. [DOI: 10.1101/2022.03.04.483019] [Reference Citation Analysis]
7 Gil B, Smith J, Tang Y, Illes P, Engel T. Beyond Seizure Control: Treating Comorbidities in Epilepsy via Targeting of the P2X7 Receptor. Int J Mol Sci 2022;23:2380. [PMID: 35216493 DOI: 10.3390/ijms23042380] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]